The Effect of Gadolinium Enhancing Lesions on Whole Brain Atrophy in Relapsing-Remitting Multiple Sclerosis
نویسنده
چکیده
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system. Gadolinium enhancing lesions on Tl-weighted MR images reflect abnormalities in the blood-brain barrier (BBB), and are used as measures of active inflammation. Enhancement has been found to precede the development of chronic lesions and clinical symptoms, suggesting that BBB breakdown may be linked to the demyelinating process. Recently, the process of atrophy in MS has begun to be evaluated using quantitative MRI. Studies have found significant atrophy of me spinal cord, corpus callosum. cerebellum, and cerebrum The mechanism of atrophy in MS has yet to be elucidated but potentially involves multiple processes. It has been suggested that BBB breakdown is the seminal event in the pathogenesis of atrophy in MS. In this study, a semi-automated whole brain segmentation method based on high-resolution dual fast spin-echo was used to determine whether whole brain atrophy over a 2yeat period is related to initial inflammatory activity.
منابع مشابه
Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.
BACKGROUND Atrophy is recognized as a measure of destructive changes in multiple sclerosis (MS). The time course and pathologic mechanisms of atrophy development are not well understood. Significant atrophy was reported to occur within 9 to 12 months in relapsing remitting MS. OBJECTIVES To test whether atrophy can be detected over short time intervals, and to evaluate its relationship to inf...
متن کاملA preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis.
Long TR and gadolinium enhanced spin echo brain MRI was performed weekly for three months in three patients with relapsing-remitting or secondary progressive multiple sclerosis. During the study, 38 new enhancing lesions were seen; 11 showed enhancement for less than four weeks, and two enhanced on only one scan. All 16 new lesions seen on long TR scans showed initial enhancement. When only eve...
متن کاملComparing the Safety and Efficacy of Ziferon and Betaferon in Patients With Remitting-Relapsing Multiple Sclerosis
Background: The present study aimed to compare the clinical efficacy and safety profile of Ziferon and Betaferon. Objectives: In total, 41 consecutive patients with relapsing forms of Multiple Sclerosis (MS) were selected from the MS outpatient clinic affiliated to Tehran University of Medical Sciences. The patients were randomly assigned into two groups. Methods: Each group either received Z...
متن کاملTestosterone treatment in multiple sclerosis: a pilot study.
OBJECTIVE To study the effect of testosterone supplementation on men with multiple sclerosis (MS). DESIGN, SETTING, AND PARTICIPANTS Men are less susceptible to many autoimmune diseases, including MS. Possible causes for this include sex hormones and/or sex chromosome effects. Testosterone treatment ameliorates experimental allergic encephalomyelitis, an animal model of MS, but the effect of ...
متن کاملMRI evidence that gadolinium-enhancing lesions seen twelve weeks after commencing rituximab treatment are associated with lower blood-brain-barrier disruption than those seen prior to treatment in patients with relapsing-remitting multiple sclerosis
INTRODUCTION The investigation of blood-brain-barrier (BBB) disruption in patients with multiple sclerosis (MS) has been limited primarily to the qualitative analysis of enhancement that is seen following the injection of chelated Gadolinium (Gd), with lesions typically being categorized as either Gdenhancing (Gd+) or not. For example, in a recent phase-II, double-blinded, 48-week-long, randomi...
متن کامل